Substituted cyclopentanes having prostaglandin activity

Details for Australian Patent Application No. 2009212570 (hide)

Owner Allergan, Inc.

Inventors Burk, Robert M.

Agent Davies Collison Cave

Pub. Number AU-A-2009212570

PCT Pub. Number WO2009/100057

Priority 12/363,996 02.02.09 US; 61/026,179 05.02.08 US

Filing date 3 February 2009

Wipo publication date 13 August 2009

International Classifications

C07C 405/00 (2006.01) Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins

A61K 31/047 (2006.01)

A61K 31/192 (2006.01)

A61P 27/02 (2006.01) Drugs for disorders of the senses

A61P 27/06 (2006.01) Drugs for disorders of the senses

Event Publications

26 August 2010 PCT application entered the National Phase

  PCT publication WO2009/100057 Priority application(s): WO2009/100057

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009212572-Systems and methods for mitigating the effects of wind turbines on radar

2009212565-Automatic control system for ceiling fan based on temperature differentials